News

November 10, 2025

Light Horse Therapeutics selected by the American Chemical Society as one of the 10 Start-ups to Watch

We are excited to share that Chemical & Engineering News has selected Light Horse Therapeutics as one of its 10 Start-Ups to Watch....

January 9, 2025

Light Horse Therapeutics Debuts With $62 Million Series A Financing

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by...

January 9, 2025

Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class therapeutics...